semaglutide compound being discontinued 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Demand Rising for 'Bootlegged' Weight-Loss

It is essential to follow manufacturer instructions and consult a healthcare professional before starting supplementation, particularly if you have existing health conditions or take prescribed medications

More personalized treatment strategies and biomarker-guided approaches may further refine GLP1 MASLD MASH treatment in the near future

Understanding how long GLP-1 medications affect gastric motility is essential for both healthcare professionals and patients, particularly when considering perioperative management, drug interactions, and the management of gastrointestinal side effects that commonly occur with this therapeutic class

Following the withdrawal of albiglutide from the market in 2018 by the manufacturer for financial reasons (257), liraglutide, injectable semaglutide, and dulaglutide should currently be the preferred choices within this class for reducing cardiovascular events until further data are available (248)

( Epub 20180402 )

GLP-1 medications such as Ozempic have transformed the treatment of Type 2 diabetes, helping millions of patients better control their blood sugar while reducing cardiovascular risk and, for many, promoting substantial weight loss